Friday, January 28, 2022

Iran Working on World’s Largest Plasma Therapy Project for COVID-19

Avatar of IFP Editorial Staff
IFP Editorial Staff
The IFP Editorial Staff is composed of dozens of skilled journalists, news-writers, and analysts whose works are edited and published by experienced editors specialized in Iran News. The editor of each IFP Service is responsible for the report published by the Iran Front Page (IFP) news website, and can be contacted through the ways mentioned in the "IFP Editorial Staff" section.

More Articles

An Iranian deputy health minister says the country has launched the world’s largest plasma therapy project by transfusing antibody-rich blood into COVID-19 patients.

Speaking at a daily online press conference on Wednesday, Deputy Health Minister Qassem Janbabaei said the world’s largest plasma therapy project for the treatment of coronavirus patients is underway in Iran.

The greatest number of studies and clinical trials for plasma therapy has been carried in Iran, he added.

The first phase of the study has involved 60 patients, while the data on 150 other patients has been also collected, the deputy minister noted.

Janbabaei said the trial stage has yielded good results so far.

“We should wait for the complete results of the research in the provinces,” he added, noting that the project is running suitably considering that there are always a large number of blood donors in Iran.

“If plasma therapy yields results, it will be an inexpensive method of treatment,” he concluded.

Coronavirus online test
If you are worried that you may have contracted the Coronavirus, take this test right now.

In late March, Masih Daneshvari Hospital in Tehran became the first medical centre in Iran to collect plasma from recovered coronavirus patients to use as a possible treatment for the disease.

When a person has COVID-19, their immune system responds by creating antibodies, which attack the virus. Over time these build up and can be found in the plasma, the liquid portion of the blood.

In theory, these antibodies could be taken from a recovered COVID-19 patient, and infused into someone recently infected with the virus.

Latest article